Closthioamide (CTA) is au nique symmetric nonribosomal peptide with six thioamide moieties that is produced by the Gram-positive obligate anaerobe Ruminiclostridium cellulolyticum. CTAdisplays potent inhibitory activity against important clinical pathogens,m aking it ap romising drug candidate.Y et, the biosynthesis of this DNAg yrase-targeting antibiotic has remained enigmatic. Using ac ombination of genome mining,g enome editing (targeted group II intron, CRISPR/Cas9), and heterologous expression, we show that CTAbiosynthesis involves specialized enzymes for starter unit biosynthesis,a mide bond formation, thionation, and dimerization. Surprisingly,C TA biosynthesis involves an ovel thiotemplated peptide assembly line that markedly differs from knownn onribosomal peptide synthetases.T hese findings providet he first insights into the biosynthesis of thioamidecontaining nonribosomal peptides and offer astarting point for the discovery of related natural products.